Interesse Geral
Opinião | Polegar da mensagem de texto, dedo em gatilho, polegar do jogador e outras lesões relacionadas a uso de smartphones.
24 Nov, 2021 | 11:10hTexting Thumb, Trigger Finger, Gamer’s Thumb and Other Smartphone Injuries – Scientific American
Delta é a última “supervariante” da Covid?
22 Nov, 2021 | 09:32hIs Delta the last Covid ‘super variant’? – The Guardian
Otimização do uso do Twitter para a disseminação de pesquisas: o estudo randomizado e controlado “Three Facts and a Story”.
22 Nov, 2021 | 09:17hConteúdos relacionados:
Perspective: How Twitter is Changing Medical Research
Keeping Up With Cardiology: Old-School Learning Versus the Twittersphere – TCTMD
Scientists on Twitter: Preaching to the choir or singing from the rooftops? – Facets
Rise of the Tweetorial – Precious Bodily Fluids
Social Medicine: Twitter in Healthcare – Journal of Clinical Medicine
University of Twitter? Scientists give impromptu lecture critiquing nutrition research – CBC
What’s your doctor reading? How social media is disrupting medical education – National Post
Comentário do autor no Twitter (fio – clique para saber mais)
We wanted to⬆️engagement with @JHepatology research
🤔Hypothesis: people are ⬆️ likely to connect with the people behind the research than the research itself
🧐Plan: Randomize papers to personal story tweets or graphical abstracts
🧐Primary Outcome: paper downloads#livertwitter pic.twitter.com/rxvbGrANRp— Elliot Tapper (@ebtapper) June 1, 2021
Pílula da Pfizer contra COVID deve ser fabricada e vendida mais barata em 95 países pobres.
17 Nov, 2021 | 13:03hPfizer COVID Pill to Be Made, Sold Cheaply in 95 Poor Countries – HealthDay
Ver também:
Pfizer agrees to license generic versions of its COVID-19 pill — in some countries – NPR
Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries – The New York Times (poucos artigos gratuitos por mês)
MSF responde à licença da Pfizer e do Medicines Patent Pool para o novo tratamento da Covid-19 – “O acordo, porém, cobre somente 53% da população mundial e exclui pessoas em diversos países de média renda, deixando esse medicamento promissor fora do alcance de milhões de pessoas.”
17 Nov, 2021 | 13:01h
Comentário no Twitter
Pfizer's deal w/ the Medicines Patent Pool for its COVID-19 treatment doesn't allow enough generic production & leaves this medicine out of reach for millions.
This is yet another restrictive voluntary license as cases continue to rise in many countries. https://t.co/WbVmUt9nrH
— Doctors w/o Borders (@MSF_USA) November 16, 2021
Doação de 1 bilhão de dólares: estimativa do custo do tempo gasto pelos pesquisadores na revisão por pares.
17 Nov, 2021 | 12:44hConteúdos relacionados:
The $450 question: Should journals pay peer reviewers?
Opinion: Peer reviewers—time for mass rebellion?
5 things we learned about peer review in 2020
Editorial: Evaluation and Peer Review During a Pandemic
Comentário no Twitter
Peer reviewers worked over 100 million hours in 2020, estimated value $1.5 billion https://t.co/tY9klsLedU Feat @ceptional pic.twitter.com/kNn1Blovxg
— Neuroskeptic (@Neuro_Skeptic) November 16, 2021
Covid: Áustria impõe lockdown a não vacinados.
16 Nov, 2021 | 12:44hCovid: Austria introduces lockdown for unvaccinated – BBC
Ver também: Austria orders nationwide lockdown for the unvaccinated – Associated Press
Pílula da Pfizer é o mais recente tratamento contra COVID a se mostrar promissor.
16 Nov, 2021 | 12:41hPfizer’s pill is the latest COVID treatment to show promise. Here are some more – The Conversation
Conteúdos relacionados:
The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.
Merck to allow other nations to produce new COVID-19 antiviral.
Video: Merck’s Covid pill could transform treatment. Here’s how it works.
How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.
What we know — and don’t know — about Merck’s new Covid-19 pill.
Merck’s Covid-19 pill is great news but may not be a game-changer.
Video | A Pill For COVID? A Doctor Explains Molnupiravir.
Merck v Pfizer: como os dois antivirais contra COVID funcionam e serão utilizados.
16 Nov, 2021 | 12:38hConteúdos relacionados:
The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.
Merck to allow other nations to produce new COVID-19 antiviral.
Video: Merck’s Covid pill could transform treatment. Here’s how it works.
How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.
What we know — and don’t know — about Merck’s new Covid-19 pill.
Merck’s Covid-19 pill is great news but may not be a game-changer.
Video | A Pill For COVID? A Doctor Explains Molnupiravir.